TrialThe American journal of cardiology2013

Effectiveness of spironolactone plus ambrisentan for treatment of pulmonary arterial hypertension (from the [ARIES] study 1 and 2 trials).

Bradley A Maron et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.